Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

cetyltrimethylammonium bromide-coated nifedipine nanoparticles

Based on

1 Patents
2011 Most recent source

Composition

1

3,5-dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate hydrochloride

nifedipine hydrochloride Nif hydrochloride nifedipine
Type Single Compound
Formula C17H18N2O6
Role core
2

hexadecyltrimethylammonium bromide

cetyltrimethylammonium bromide cetrimonium bromide CTAB
Type Single Compound
Formula C19H42BrN
Role layer

Properties

General physical and chemical properties

Property Value Source
Zeta potential

1 more entry available to subscribers only.

Or, view sample content

Applications

Characterization

Method Source
scanning electron microscopy

0 more entry available to subscribers only.

Or, view sample content

Biological effects

Preparation

Method 1

Type: Chemical synthesis
Source:
Starting materials
  • 3,5-dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate hydrochloride
  • hexadecyltrimethylammonium bromide
  1. Cf2nnZq9hRxAHeR2h6
Product

cetyltrimethylammonium bromide-coated nifedipine nanoparticles

Method 2

Type: Chemical synthesis
Source:
Starting materials
  • 3,5-dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate hydrochloride
  • hexadecyltrimethylammonium bromide
  1. APPjXqmr07eYObkoobrJhsycEI
Product

cetyltrimethylammonium bromide-coated nifedipine nanoparticles

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial